Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Mar 2026, Jul 2026 and Sep 2026.
- Largest single sale: $1.4M (2,400 shares) of Madrigal Pharmaceuticals, Inc. on Dec 4, 2025. Filing
- Last sale before this period: Sep 9, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | President and CEO, Director | Sep 13, 2023 | Sep 11, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 11, 2026, Madrigal Pharmaceuticals, Inc.: sold 5,221 shares for $2.8M, under a disclosed plan. 1 filing: 1
- Sep 9, 2026, Madrigal Pharmaceuticals, Inc.: sold 6,362 shares for $3.4M, under a disclosed plan. 1 filing: 1
- Jul 20, 2026, Madrigal Pharmaceuticals, Inc.: sold 2,500 shares for $1.4M, to cover taxes. 1 filing: 1
- Jul 17, 2026, Madrigal Pharmaceuticals, Inc.: 50,000 shares vested. 1 filing: 1
- Mar 6, 2026, Madrigal Pharmaceuticals, Inc.: sold 1,663 shares for $718K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.